NCT06359080View on ClinicalTrials.gov

Transcranial Photobiomodulation for Reducing Autism Symptoms in Children - Open Label Study (TPBMASDOL)

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

May 8, 2022

Primary Completion Date

December 11, 2022

Study Completion Date

December 11, 2022

Conditions
Autism Spectrum Disorder
Interventions
DEVICE

Cognilum TM: Light Treatment Condition

The children will wear the CognilumTM device for up to 15 minutes at a time, twice a week, for a period of 10 weeks.

Trial Locations (2)

10019

Dr. Steingold Psychology PC, New York

11229

Dr. Steingold Psychology PC, Brooklyn

All Listed Sponsors
lead

JelikaLite LLC

INDUSTRY